On this page
Jonathan Barrett Mackenzie
Insider
First SEC filing: March 21, 2022 · Latest: March 21, 2022
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | MED | F | 862 | $9.59 | $8,267 | 10,008 Direct | -7.93% | Disposed | 22.3% (price as of 2026-10-02) |
| March 25, 2026 | MED | A | 10,830 | · | · | 20,838 Direct | +108.21% | Acquired | (price as of 2026-10-02) |
| March 17, 2026 | MED | F | 70 | $10.05 | $704 | 10,870 Direct | -0.64% | Disposed | 16.7% (price as of 2026-10-02) |
| March 13, 2026 | MED | F | 198 | $9.62 | $1,905 | 10,940 Direct | -1.78% | Disposed | 21.9% (price as of 2026-10-02) |
| March 25, 2025 | MED | A | 7,671 | · | · | 11,138 Direct | +221.26% | Acquired | (price as of 2026-10-02) |
| March 17, 2025 | MED | F | 99 | $14.35 | $1,421 | 3,467 Direct | -2.78% | Disposed | -18.3% (price as of 2026-10-02) |
| March 16, 2025 | MED | F | 60 | $13.94 | $836 | 3,566 Direct | -1.65% | Disposed | -15.9% (price as of 2026-10-02) |
| March 13, 2025 | MED | F | 280 | $13.87 | $3,884 | 3,626 Direct | -7.17% | Disposed | -15.4% (price as of 2026-10-02) |
| Sept. 13, 2024 | MED | F | 11 | $18.90 | $208 | 3,906 Direct | -0.28% | Disposed | -37.9% (price as of 2026-10-02) |
| March 15, 2024 | MED | F | 51 | $36.61 | $1,867 | 4,000 Direct | -1.26% | Disposed | -68.0% (price as of 2026-10-02) |
| March 15, 2024 | MED | F | 83 | $36.61 | $3,039 | 3,917 Direct | -2.08% | Disposed | -68.0% (price as of 2026-10-02) |
| March 13, 2024 | MED | A | 2,565 | · | · | 4,051 Direct | +172.61% | Acquired | (price as of 2026-10-02) |
| Sept. 13, 2023 | MED | F | 10 | $81.08 | $811 | 1,486 Direct | -0.67% | Disposed | -85.5% (price as of 2026-10-02) |
| March 17, 2023 | MED | A | 906 | · | · | 1,496 Direct | +153.56% | Acquired | (price as of 2026-10-02) |
| March 16, 2023 | MED | F | 57 | $104.46 | $5,954 | 590 Direct | -8.81% | Disposed | -88.8% (price as of 2026-10-02) |
| Sept. 13, 2022 | MED | F | 10 | $124.56 | $1,246 | 647 Direct | -1.52% | Disposed | -90.6% (price as of 2026-10-02) |
| March 16, 2022 | MED | A | 548 | · | · | 657 Direct | +502.75% | Acquired | (price as of 2026-10-02) |
| Sept. 13, 2021 | MED | A | 109 | · | · | 109 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.